Studies have shown that loss of DNA heterozygous mutations and elevated CpG island methylation in the TGM3 promoter, which in turn silenced transcription and down-regulated TGM3 expression in laryngeal carcinomas (He et al., 2002). The gene discussed is TGM3; the disease is laryngeal carcinoma.